Call Us: 1.800.873.5297

By

New Research: Testosterone Drugs Linked to Increased Risk of Blood Clots, Heart Attack and Stroke

The FDA recently announced the launch of an investigation of the cardiovascular risks associated with testosterone therapy. The medical safety alert is to warn men of potential risks and/or side effects associated with testosterone therapy.

Studies have shown that, as early as one month and up to the first 90 days after starting testosterone therapy, dangerous blood clots can occur. Further the risk for men over the age of 65 doubles for a heart attack. There is a nearly triple the risk of suffering a serious or fatal complication for men under 65 years of age that have pre-existing heart disease. The risk to men with unknown inherited clotting disorders is higher for developing clots. These cardiovascular risks are generally not set forth in the product labels.

Testosterone therapy was approved by the FDA to treat abnormally low testosterone levels. However, some of the manufacturers of these products are promoting their use for conditions not necessarily related to low testosterone levels, such as energy loss, mood changes, and reduced sex drive among others. These conditions may not be related to low testosterone, but simply the aging process or improper diet and exercise. Because of these aggressive marketing strategies, the estimated sales of testosterone drugs are projected to reach $5 billion by 2017.

These products include:

  • Androgel®
  • Androderm®
  • Fortestra®
  • Axiron®
  • Testim®
  • Bio-T-Gel®
  • Delatestryl®
  • Depo-Testosterone®
  • Striant®
  • Testopel®

The Pharmaceutical Litigation Department at Schlichter, Bogard & Denton, LLP represent clients nationwide who have suffered serious and fatal injuries as a result of dangerous pharmaceutical medications. At Schlichter, Bogard & Denton, LLP, we are committed to protecting the rights of persons injured by pharmaceutical companies.

The attorneys at Schlichter, Bogard & Denton, LLP are offering a free case review with no further obligation to those who have suffered injuries after using testosterone therapy. If you suffered injuries after using testosterone therapy, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.

The choice of a lawyer is an important decision and should not be based solely on advertisements.

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.